Baidu
map

4+7带量采购大势下 昔日糖尿病领域明星企业销售端该如何创新?

2019-05-06 罗美 动脉网

一张医保卡多人使用、套取药品倒买倒卖……北京欺诈骗取医疗保障基金的手段不断提升,呈现出方式多样、隐蔽性强、团伙作案,甚至通过高科技手段骗保等趋势。北京将探索建立“黑名单”制度联合惩戒,并探索将人脸识别技术等应用于门诊、住院等环节,解决骗保问题。这是北京市医疗保障局局长于鲁明在6日召开的北京市医疗保障工作会议上透露的。于鲁明表示,北京医保基金监管面临的问题复杂、严峻,一方面是由于较长时间以来,北京市

一张医保卡多人使用、套取药品倒买倒卖……北京欺诈骗取医疗保障基金的手段不断提升,呈现出方式多样、隐蔽性强、团伙作案,甚至通过高科技手段骗保等趋势。北京将探索建立“黑名单”制度联合惩戒,并探索将人脸识别技术等应用于门诊、住院等环节,解决骗保问题。

这是北京市医疗保障局局长于鲁明在6日召开的北京市医疗保障工作会议上透露的。

于鲁明表示,北京医保基金监管面临的问题复杂、严峻,一方面是由于较长时间以来,北京市各级各类医疗机构执行的是以药和耗材补医等运行机制,使得过度医疗、过度使用药品耗材具有普遍性。另一方面,一些医疗机构在逐利机制驱使下,引导患者过度就医造成医疗费用快速成倍增长,像一些社区一级医疗机构年医疗费用,最高的竟达到近亿元。

北京的医疗机构吸引了大量外埠患者。于鲁明指出,一些不法公司为外埠患大病的病人虚构劳动关系,骗取北京市医保待遇。还有的医疗机构利用单病种人头按天收费政策,在本来仅审批100张床位的医院,不择手段挤下近300位病人,严重损害参保人的权益和基金安全。

“对这些现象和问题,必须保持高度警惕,敢于担当、敢于出手、敢于亮剑。”于鲁明强调,北京将在基金安全监管上下功夫,提高医保管理智能化、信息化和精细化水平。

他表示,北京将持续打击欺诈骗保,通过“发现一批、査处一批、公布一批、防范一批、教育一批、移送一批”,全面加大对欺诈骗保行为的震慑力度。对所有定点医药机构实现督查全覆盖,针对薄弱环节,确定1至2项专项治理重点,限期整改到位,并引导参保人员切实认识到医保基金是自己的救命钱,共同维护医保基金安全可持续运行。

他称,北京还将推进医保诚信评价体系建设,健全信息披露制度,对定点医药机构进行综合评价和排名,建立按比例末位退出机制。探索建立“黑名单”制度,发挥联合惩戒威慑力。加强与卫生健康、公安等部门的联动配合,建立基金监管协调常态化工作机制,构建“一案多査”、“一案多处”制度,推动基金监管无缝衔接、闭环管理

于鲁明强调,北京将依托科技力量,建设智慧医保。探索将人脸识别技术、就诊信息互联互通、住院登记时间采集比对、医疗机构药品和耗材购销存信息同步采集、医保缴费信息与纳税信息协查比对等机制,应用于门诊、住院和后台监控等环节,解决一卡多用、挂床住院、替换药品、虚报费用、虚假用工等骗保问题。

与此同时,北京将加强数据标准化建设,推进中药饮片标准化、门诊诊断标准化和药品说明书电子化,优化药品监测平台,精准分析药品支出异动,追踪存在过度医疗行为的定点医疗机构和医师,及时干预提醒;强化医疗机构医保费用増长趋势分析监测,准确把握医疗机构价值取向特点,对增速排名前50位的医疗机构,尤其是民营医疗机构,进行精准监管;充分挖据运用医保大数据,探寻医疗市场服务需求供给洼地,引导促进北京医疗和科技企业创新发展。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1687337, encodeId=3764168e33742, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Sun Aug 18 01:04:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941146, encodeId=4ca919411460b, content=<a href='/topic/show?id=1a5213229f' target=_blank style='color:#2F92EE;'>#4+7带量采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1322, encryptionId=1a5213229f, topicName=4+7带量采购)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 22 13:04:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285733, encodeId=ba971285e33f7, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398821, encodeId=0ccd139882188, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456247, encodeId=f3e5145624edd, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532858, encodeId=61ac1532858f9, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042416, encodeId=050f104241699, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon May 06 21:04:00 CST 2019, time=2019-05-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1687337, encodeId=3764168e33742, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Sun Aug 18 01:04:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941146, encodeId=4ca919411460b, content=<a href='/topic/show?id=1a5213229f' target=_blank style='color:#2F92EE;'>#4+7带量采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1322, encryptionId=1a5213229f, topicName=4+7带量采购)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 22 13:04:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285733, encodeId=ba971285e33f7, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398821, encodeId=0ccd139882188, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456247, encodeId=f3e5145624edd, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532858, encodeId=61ac1532858f9, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042416, encodeId=050f104241699, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon May 06 21:04:00 CST 2019, time=2019-05-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1687337, encodeId=3764168e33742, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Sun Aug 18 01:04:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941146, encodeId=4ca919411460b, content=<a href='/topic/show?id=1a5213229f' target=_blank style='color:#2F92EE;'>#4+7带量采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1322, encryptionId=1a5213229f, topicName=4+7带量采购)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 22 13:04:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285733, encodeId=ba971285e33f7, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398821, encodeId=0ccd139882188, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456247, encodeId=f3e5145624edd, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532858, encodeId=61ac1532858f9, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042416, encodeId=050f104241699, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon May 06 21:04:00 CST 2019, time=2019-05-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1687337, encodeId=3764168e33742, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Sun Aug 18 01:04:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941146, encodeId=4ca919411460b, content=<a href='/topic/show?id=1a5213229f' target=_blank style='color:#2F92EE;'>#4+7带量采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1322, encryptionId=1a5213229f, topicName=4+7带量采购)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 22 13:04:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285733, encodeId=ba971285e33f7, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398821, encodeId=0ccd139882188, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456247, encodeId=f3e5145624edd, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532858, encodeId=61ac1532858f9, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042416, encodeId=050f104241699, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon May 06 21:04:00 CST 2019, time=2019-05-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1687337, encodeId=3764168e33742, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Sun Aug 18 01:04:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941146, encodeId=4ca919411460b, content=<a href='/topic/show?id=1a5213229f' target=_blank style='color:#2F92EE;'>#4+7带量采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1322, encryptionId=1a5213229f, topicName=4+7带量采购)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 22 13:04:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285733, encodeId=ba971285e33f7, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398821, encodeId=0ccd139882188, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456247, encodeId=f3e5145624edd, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532858, encodeId=61ac1532858f9, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042416, encodeId=050f104241699, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon May 06 21:04:00 CST 2019, time=2019-05-06, status=1, ipAttribution=)]
    2019-05-08 hyf030
  6. [GetPortalCommentsPageByObjectIdResponse(id=1687337, encodeId=3764168e33742, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Sun Aug 18 01:04:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941146, encodeId=4ca919411460b, content=<a href='/topic/show?id=1a5213229f' target=_blank style='color:#2F92EE;'>#4+7带量采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1322, encryptionId=1a5213229f, topicName=4+7带量采购)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 22 13:04:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285733, encodeId=ba971285e33f7, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398821, encodeId=0ccd139882188, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456247, encodeId=f3e5145624edd, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532858, encodeId=61ac1532858f9, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042416, encodeId=050f104241699, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon May 06 21:04:00 CST 2019, time=2019-05-06, status=1, ipAttribution=)]
    2019-05-08 wolongzxh
  7. [GetPortalCommentsPageByObjectIdResponse(id=1687337, encodeId=3764168e33742, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Sun Aug 18 01:04:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941146, encodeId=4ca919411460b, content=<a href='/topic/show?id=1a5213229f' target=_blank style='color:#2F92EE;'>#4+7带量采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1322, encryptionId=1a5213229f, topicName=4+7带量采购)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 22 13:04:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285733, encodeId=ba971285e33f7, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398821, encodeId=0ccd139882188, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456247, encodeId=f3e5145624edd, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532858, encodeId=61ac1532858f9, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed May 08 09:04:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042416, encodeId=050f104241699, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon May 06 21:04:00 CST 2019, time=2019-05-06, status=1, ipAttribution=)]
    2019-05-06 misszhang

    谢谢MedSci提供最新的资讯

    0

相关资讯

Circulation:钠-葡萄糖共转运体2抑制剂可降低24小时血压

对盐敏感的糖尿病和不受控制的夜间高血压患者发生心血管疾病和死亡的风险很高。SACRA 研究(钠-葡萄糖共转运体2[SGLT2] 抑制剂和血管紧张素受体阻滞剂[ARB]联合疗法用于糖尿病和不受控制的夜间高血压)评估了依帕列净(empagliflozin)联合现有降压药对血压(BP)的影响。本研究是在日本开展的多中心、双盲的平行实验,招募2型糖尿病和进行稳定的抗高血压治疗(包括血管紧张素受体阻滞剂)的

Circulation:依帕列净可有效用于糖尿病合并高血压的黑人患者

Empagliflozin(依帕列净)是一种用于2型糖尿病(T2DM)的钠-葡萄糖共转运体2抑制剂,可降低T2DM患者的血压(BP)和心血管疾病的死亡率。但其是否可用于黑种人尚未有相关研究。研究人员开展一24周研究,评估依帕列净用于T2DM和高血压黑人患者的疗效和安全性。共招募了150位患者,52.7%为男性,平均年龄56.8(9.3)岁;平均T2DM患病时间9.3(7.1)年。起始时的重要参数:

NEJM:利拉鲁肽联合二甲双胍治疗青少年II型糖尿病

在儿童和青少年II型糖尿病中,利拉鲁肽联合二甲双胍可有效地改善患者血糖

Lancet Diabetes Endo:新型胰岛素输注设备可降低I型糖尿病患者低血糖风险

使用具备低血糖预警暂停功能的持续皮下胰岛素输注设备可显著降低I型糖尿病患者低血糖风险

Sci Transl Med:一种流行的食品添加剂,或增加糖尿病和肥胖风险

近日,根据美国哈佛大学T.H.Chan公共卫生学院领导的一项研究显示,食用广泛用于烘焙食品、动物饲料和人造香料的丙酸盐,似乎会增加几种与肥胖和糖尿病风险相关的激素水平。

Diabetes Care:糖尿病个体化饮食计划——ADA的全新建议

近日,美国糖尿病协会(ADA)发布了有关营养治疗的新共识,强调临床医生需要为糖尿病及糖尿病前期患者制定个体化的饮食计划。共识强调,鉴于糖尿病及糖尿病前期所影响的人群非常广泛,文化背景、个人喜好、合并症及所生活的社会经济环境等存在较大差异,故一刀切的饮食计划对于糖尿病防治作用并不明显,糖尿病营养治疗的饮食计划需要坚持个体化。该新共识在ADA 2014 糖尿病营养管理指南基础上编写而成,已于201

Baidu
map
Baidu
map
Baidu
map